Law Seminars International (LSI) will be offering a one-hour telebriefing on the Federal Circuit's recent decision in Centocor Ortho Biotech, Inc. v. Abbott Laboratories on March 31, 2011 from 3:00-4:00 PM (ET). Patent Docs author Dr. Donald Zuhn of McDonnell Boehnen Hulbert & Berghoff LLP will moderate panel including Courtenay Brinckerhoff of Foley & Lardner LLP and Dr. Chris Holman, Associate Professor of Law at the University of Missouri-Kansas City School of Law. The panel will provide an overview of the Federal Circuit's decision and discuss its implications. Among the topics to be covered are:
• Whether the test applied in Centocor is appropriate and workable for antibody claims,
• How Centocor fits with earlier Federal Circuit written description precedent,
• Whether it is possible to reconcile Centocor with Noelle and the USPTO Written Description Guidelines,
• Whether Centocor validates Chief Judge Rader's assertion that Lilly written description is nothing more than a "wildcard" for invalidating "unworthy" patent claims.
The registration fee is $125 per caller and $50 each additional person on the same line who desires continuing education credit. Those interested in registering for the telebrief, can do so here. Additional information regarding the telebriefing can be found here.
Comments